NEW YORK – Liquid biopsy technology firm Freenome said Wednesday that it has closed an oversubscribed $270 million Series C financing round, led by new investor Bain Capital Life Sciences and existing investor Perceptive Advisors.
NEW YORK – Liquid biopsy technology firm Freenome said Wednesday that it has closed an oversubscribed $270 million Series C financing round, led by new investor Bain Capital Life Sciences and existing investor Perceptive Advisors.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.